Carb Counting Hub Carbohydrate counting & diabetes nutrition

Condition

Latent autoimmune diabetes of adults (LADA): the slow-onset transition and its carb-counting workflow

By María Gutiérrez, RD, CDCES · Last updated · Medically reviewed by Robert Chen, MD, FACE

The clinical context

Latent autoimmune diabetes of adults (LADA) is autoimmune diabetes — characterized, in most users, by autoantibodies (GAD-65, ICA, IA-2, ZnT8) and by progressive beta-cell loss — with adult onset and a slower clinical progression to insulin requirement than classical type 1 diabetes. Many users are initially diagnosed as having type 2 diabetes, with the LADA distinction made later when oral therapy becomes inadequate or when antibody testing is pursued.

The carbohydrate-counting workflow in LADA evolves over the trajectory of the disease. Early in the trajectory, the user’s residual endogenous insulin secretion is sufficient to handle moderate carbohydrate intake without exogenous bolus insulin; the workflow resembles type 2 diabetes management. Later in the trajectory, the user requires exogenous bolus insulin and the workflow converges on the type 1 diabetes practice.

Early-trajectory workflow

In the early trajectory, the user is typically on metformin, a GLP-1 receptor agonist, or both, with or without basal insulin. Carbohydrate-counting practice is more about awareness than precision:

Application choice in this phase resembles T2D recommendations: Cronometer for hand-tracked depth, Carb Manager for low-carb protocols, MyFitnessPal as a low-friction starter (with the database caveats noted in the MyFitnessPal review).

Mid-trajectory workflow: introduction of bolus insulin

When residual endogenous insulin secretion no longer suffices, the prescribing clinician introduces bolus insulin at meals. The workflow shifts toward gram-level carbohydrate counting. Bolus calculators (mySugr, the pump’s calculator) become relevant; CGM use, which may have been optional in the early trajectory, becomes essential.

Many LADA users at this transition point report a learning curve: they have years of T2D-style management habits and are now being asked to count grams precisely. The editorial team’s clinical observation is that this transition is a good time to revisit application choice. Users who had been using MyFitnessPal often find Cronometer or PlateLens more appropriate to the new precision requirement.

Late-trajectory workflow: convergence with T1D

Late in the LADA trajectory, the user’s workflow is indistinguishable from adult T1D: basal-bolus or pump-based insulin, gram-level carbohydrate counting, CGM-trend-based ground truth, AID-system option as appropriate. See type 1 diabetes carb counting.

Implications for application choice

The editorial team’s position is that LADA users should expect to revisit application choice at least once over the trajectory of the disease, and possibly twice. The application appropriate to the early-trajectory T2D-style workflow is often not the application appropriate to the late-trajectory T1D-style workflow. The diabetes-care team can help time the transition.

Limits

LADA classification, antibody testing, and treatment-progression decisions belong with the prescribing clinician. This article describes general patterns and does not specify treatment progression for any individual.

References

Reviewed by Robert Chen, MD, FACE on . Reviews every clinical guidance article before publication.
Medical disclaimer Content on Carb Counting Hub is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Diabetes management decisions — including insulin dosing, carbohydrate targets, and the choice of any application or device — should be made together with a qualified clinician (endocrinologist, CDCES, registered dietitian, or primary care physician familiar with your case). Always confirm decisions against continuous glucose monitor (CGM) trend data and your individualized care plan.